Suppr超能文献

应用质谱分析技术对脐血血清蛋白质组进行分析,以区分宫内发育受限儿、小于胎龄儿和正常儿。

Mass spectrometric profiling of cord blood serum proteomes to distinguish infants with intrauterine growth restriction from those who are small for gestational age and from control individuals.

机构信息

Department of Obstetrics and Gynecology, Medical Faculty, RWTH Aachen, Aachen, Germany.

Department of Obstetrics and Gynecology, Medical Faculty, RWTH Aachen, Aachen, Germany; Proteome Center Rostock, Medical Faculty and Natural Science Faculty, University of Rostock, Rostock, Germany.

出版信息

Transl Res. 2014 Jul;164(1):57-69. doi: 10.1016/j.trsl.2013.12.003. Epub 2013 Dec 10.

Abstract

Intrauterine growth restriction (IUGR) is a multifactorial condition in that the fetus does not reach its genetically given growth potential. Besides its contribution to perinatal mortality, it is a risk factor for cardiovascular and metabolic diseases later in life. The diagnosis is based on antenatal sonography, which allows differentiating between IUGR and fetuses that are small by constitution (small for gestational age [SGA]). Yet, neither a clinical nor a biochemical tool is available to confirm reliably the diagnosis of IUGR postnatally. Recently, we identified umbilical cord blood proteins of the apolipoprotein family by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with differential signal intensities between the IUGR group and a control group. We hypothesized that identified molecules have the potential to generate a proteome profile specific for IUGR. A total of 114 serum samples (42 from the IUGR group, 12 from the SGA group, and 60 from the control group) of the umbilical vein (99 samples) and umbilical artery (15 samples) were analyzed. Sample quality was estimated by determining the abundance of hemoglobin (hemolysis) and CXC-motif chemokines CXCL4 and CXCL7 (platelet activation). Samples passing the quality criteria were forwarded to multiplex apolipoprotein profiling. Assay performance was tested with the sample sets, resulting in a sensitivity of 0.91 and a specificity of 0.85 in the test set with venous blood samples. Arterial cord blood samples followed the trend (sensitivity, 0.67; specificity, 0.85). SGA samples grouped together with the control samples. We conclude that the proteome profiling signature is confirmatory to clinical surveillance with the potential to identify neonates with IUGR postnatally in low-birth weight babies born at uncertain gestational age when antenatal sonography data have not been recorded.

摘要

胎儿宫内生长受限(IUGR)是一种多因素的情况,即胎儿未能达到其遗传赋予的生长潜力。除了对围产期死亡率的贡献外,它还是日后发生心血管和代谢疾病的危险因素。该诊断基于产前超声检查,可区分 IUGR 与因遗传因素而体型较小(小于胎龄儿[SGA])的胎儿。然而,目前既没有临床工具也没有生化工具可在产后可靠地确认 IUGR 的诊断。最近,我们通过基质辅助激光解吸/电离飞行时间质谱技术鉴定了脐血载脂蛋白家族的蛋白,发现 IUGR 组和对照组之间存在差异信号强度。我们假设鉴定出的分子具有产生特定于 IUGR 的蛋白质组图谱的潜力。总共分析了 114 份血清样本(IUGR 组 42 份,SGA 组 12 份,对照组 60 份)的脐静脉(99 份样本)和脐动脉(15 份样本)。通过确定血红蛋白(溶血)和 CXC 基序趋化因子 CXCL4 和 CXCL7(血小板活化)的丰度来评估样本质量。通过质量标准的样本被送到多重载脂蛋白分析中。用样本集测试了检测性能,结果显示静脉血样本的测试集的灵敏度为 0.91,特异性为 0.85。动脉脐血样本也呈现出相同的趋势(灵敏度为 0.67,特异性为 0.85)。SGA 样本与对照组样本聚集在一起。我们得出结论,蛋白质组分析谱与临床监测具有一致性,具有在未记录产前超声数据的不确定胎龄出生的低体重儿中识别产后 IUGR 新生儿的潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验